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Hydrophobic mismatch is a well-recognized principle in the interaction of transmembrane proteins with
lipid bilayers. This concept was extended here to amphipathic membranolytic a-helices. Nine peptides with
lengths between 14 and 28 amino acids were designed from repeated KIAGKIA motifs, and their helical
nature was confirmed by circular dichroism spectroscopy. Biological assays for antimicrobial activity and
hemolysis, as well as fluorescence vesicle leakage and solid-state NMR spectroscopy, were used to correlate
peptide length with membranolytic activity. These data show that the formation of transmembrane pores is
only possible under the condition of hydrophobicmatching: the peptides have to be long enough to span the
hydrophobic bilayer core to be able to induce vesicle leakage, kill bacteria, and cause hemolysis. By
correlating the threshold lengths for biological activity with the biophysical results on model vesicles, the
peptides could be utilized as molecular rulers to measure the membrane thickness in different cells.
M
embrane-active antimicrobial peptides (AMPs) are found in almost all types of organisms and constitute
a host defense system against microorganisms1. Over 2000 AMPs are known2 and can be classified
according to origin, activity or structure1–3. Linear cationic amphipathic a-helices are themost common
AMPs and also have the widest antimicrobial activity spectrum, some well-known examples being magainins
from frogs4 and LL-37 from humans5. Besides exploring natural AMPs from a wide variety of organisms, much
effort has also been spent to obtain new peptides with improved activities. One approach is to modify natural
sequences, while another strategy is based on the design of amphipathic sequences from scratch, as in the case of
MSI-103 with the regular repeat (KIAGKIA)3-NH23. This heptameric motif was based on the sequence of PGLa, a
member of the magainin family of antimicrobial peptides from the African frog Xenopus laevis6. The full-length
peptide was optimized by simplifying the sequence to contain only four types of amino acid, and by increasing the
positive charge while maintaining the overall amphipathic character3. MSI-103 was found to have a higher
antimicrobial activity than the parent peptide, while hemolytic side effects were reduced3,7.
The parent peptide of MSI-103, PGLa, as well as magainin 2 from the same family, have been proposed to
permeabilize membranes by forming pores across the lipid bilayer8–10. Pores are attributed to peptides in a
transmembrane orientation, forming either a so-called ‘‘barrel-stave’’ as described for alamethicin11, or a ‘‘tor-
oidal wormhole’’ that includes lipid head groups as reported, e.g., for melittin12. For melittin, there is strong
indication of membranous pores from X-ray studies, but the orientation of the peptide is not visible from these
experiments12. Complementary methods, such as solid-state NMR and oriented circular dichroism, have been
used to monitor directly the alignment of helical peptides and thereby discriminate a surface-bound state from a
stable transmembrane alignment and from any tilted state in between13–19. This way, MSI-103 was shown to self-
assemble and start to insert into lipid bilayers in a similar manner to its parent peptide PGLa, but at a lower
threshold concentration7,15,20–24.
The same kind of solid-state NMR studies have also been instrumental in deciphering the phenomenon of
hydrophobic matching, which is known to affect the tilt angle and assembly of fully inserted transmembrane
protein segments25–29. It is generally recognized that longmembrane-spanning helices can become tilted tomatch
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the bilayer thickness25,30–32, and lipid bilayers are in turn able to adjust
their thickness or lipid phase to accommodate very short hydro-
phobic segments30,32. So far, the concept of hydrophobic mismatch
has only been applied to fully hydrophobic transmembrane helices.
The effect of peptide length on the activity of amphipathic AMPs
has been investigated in numerous studies33–40. However, we are not
aware of any attempt to monitor or interpret their membranolytic
activity in terms of the matching between peptide length and mem-
brane thickness. Therefore, to extend the elegant principle of hydro-
phobic matching for the first time to amphipathic helices, we
investigate here a series of MSI-derived peptides with different
lengths. Given the underlying repeat unit KIAGKIA, we call them
KIA[n] peptides, where n is the number of amino acids in each
peptide. Our original aim was twofold: (i) to find the optimal length
of peptides with high antimicrobial activity and low hemolytic side
effects, and (ii) to re-examine the classical pore formation hypo-
thesis, which has been under some critical debate recently41–45.
Namely, if the amphipathic peptides were to form stable or transient
pores built from genuinely transmembrane helices, they would
clearly require a minimum length to span the membrane. In that
case one would expect to find a threshold minimum length for activ-
ity, which would also have to vary with the thickness of the target
membrane. On the other hand, it has been argued that this class of
antimicrobial peptides can kill bacteria either in a detergent-like
fashion by permeabilizing the lipid bilayer according to the ‘‘carpet
model’’, where the peptides remain crowded on the membrane sur-
face46, or by translocating the membrane to find some intracellular
target47. In those cases, even peptides that are much too short to span
the membrane could be active48,49 (unless of course the translocation
process itself occurs via a transient transmembrane pore). To study
the fundamental effect of membrane thickness on peptide activity in
complementary biological and biophysical ways, we used antibacter-
ial and hemolysis assays on living cells, as well as fluorescence leakage
experiments with model lipid vesicles composed of synthetic lipids
with defined acyl chain length. Additionally, solid-state NMR was
employed to examine the orientation of peptides in DMPC (1,2-
dimyristoyl-sn-glycero-3-phosphatidylcholine) bilayers, in order to
find out whether a length-dependent re-alignment of the amphi-
pathic helices occurs in this well-defined membrane system.
Results
Peptide synthesis and characterization by CD. A total of nine
peptides of the KIA series with lengths 14–28 amino acids were
synthesized as listed in Table 1, with a non-perturbing 15N-NMR
label at the backbone amide of Ala-10. Circular dichroism (CD)
was used to compare their secondary structure in different media.
In phosphate buffer, all peptides showed random coil spectra (see
Supplementary Figure S1A). In small unilamellar DMPC/DMPG
(1,2-dimyristoyl-sn-glycero-3-phosphatidylglycerol) (351 mol/mol)
vesicles, at a peptide-to-lipid molar ratio (P/L) of 1550, the line
shapes were all very similar to one another, typical of a-helices (see
Supplementary Figure S1B). Clearly, all peptides are unstructured
in solution but fold as a-helices when bound to membranes. A
deconvolution of the CD spectra was performed, giving 68–83% a-
helical content of the peptides, as shown in Table 1. A more complete
table of the deconvolution result is shown in Table S1.
Antimicrobial activity. The effect of the peptides on bacteria was
determined using a minimal inhibition concentration (MIC) assay.
As seen in Table 2 (and in Supplementary Table S2), there is a clear
correlation between peptide length and biological activity, as a
minimum length is required for peptides to be antimicrobially
effective. Interestingly, this threshold length differs for the different
bacterial strains. In Escherichia coli (DSM 1103), KIA14 and KIA15
are completely inactive, while KIA17 and KIA19 show some activity,
and KIA21 and longer peptides show high activity. In Pseudomonas
aeruginosa (DSM 1117), KIA19 and shorter analogs are inactive,
KIA21 and KIA22 somewhat active, while for full activity 24 or
more amino acids are needed. In Staphylococcus aureus (DSM
1104), the threshold is more distinct: KIA19 and shorter peptide
are inactive, whereas KIA21 and longer peptides are highly active.
In Enterococcus faecalis (DSM 2570), hardly any activity is found for
KIA22 and shorter peptides, while KIA24 and KIA26 show some
medium activity (compared to the shorter peptides), and only
KIA28 is much more active than the shorter peptides. In summary,
there is a clear threshold length in all bacterial strains, as peptides
shorter than the threshold have much lower activity than the longer
ones.We also note that the activity of the control peptide PGLa (with
21 amino acids) most closely resembles that of KIA17 and KIA19.
Hemolysis. Amphipathic antimicrobial peptides show membranolytic
effects not only against bacteria, but they can also permeabilize
eukaryotic cells such as erythrocytes. Hemolytic activities of the KIA
peptides are summarized in Figure 1A–D (and in Supplementary Table
S3), recorded for several different peptide concentrations. A clear jump
in activity is observed for the series of peptides with different lengths, as
already seen in the MIC assays. The short KIA14 to KIA19 gave very
low hemolysis, even at a high peptide concentration of 512 mg/mL.
KIA21 and KIA22 showed considerable activity only at or above
128 mg/mL, while KIA24 and longer peptides caused strong
hemolysis already at 8 mg/mL and reach 100% hemolysis at the
highest concentration used. In summary, the threshold length of KIA
peptides to permeabilize erythrocyte membranes is around 21 to 22
amino acids, and superimposed on this jump is a monotonous
increase in hemolysis with peptide length and concentration.
Vesicle leakage. In the MIC and hemolysis assays above with living
cells, it was not possible to control the composition of the membrane
lipids, and the acyl chain lengths are not known. Therefore, we
Table 1 | Synthesized peptides used in this study. The highlighted Ala-10 was labelled with15N at the backbone amide
Peptide Sequence Helicitya/% Lengthb/A˚
KIA14 KIAGKIA KIAGKIA-NH2 74 21
KIA15 KIAGKIA KIAGKIA K-NH2 69 22.5
KIA17 KIAGKIA KIAGKIA KIA-NH2 83 25.5
KIA19 KIAGKIA KIAGKIA KIAGK-NH2 82 28.5
KIA21c KIAGKIA KIAGKIA KIAGKIA-NH2 83 31.5
KIA22 KIAGKIA KIAGKIA KIAGKIA K-NH2 68 33
KIA24 KIAGKIA KIAGKIA KIAGKIA KIA-NH2 73 36
KIA26 KIAGKIA KIAGKIA KIAGKIA KIAGK-NH2 71 39
KIA28d KIAGKIA KIAGKIA KIAGKIA KIAGKIA-NH2 76 42
aFrom CD data deconvolution using the CONTIN-LL algorithm74.
bApproximate length, assuming fully helical peptides with a length of 1.5 A˚ per residue for an ideal a-helix.
cAlso called MSI-1033.
dAlso called MSI-11273.
www.nature.com/scientificreports
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performed complementary in vitro experiments, by measuring the
leakage of fluorescent dye from small unilamellar vesicles with well-
defined membrane thickness. Different synthetic lipids were chosen
with distinctly different acyl chain lengths. In all cases, a 151 (mol/
mol) mixture of zwitterionic phosphatidylcholine (PC) and anionic
phosphatidylglycerol (PG) head groups was used. Anionic lipids are
known to be the main components of bacterial membranes, which
contain in many cases well over 50% PG50. Furthermore, a negative
charge is necessary to attract the water-soluble cationic peptides
electrostatically to the vesicles48,51. Leakage curves were measured
at different P/L ratios, over 10 minutes after addition of the vesicle
suspension to the peptide solution. At very low peptide concentration
only partial leakage could be achieved, but with a higher P/L of 1525
or more, there was in almost all cases either no leakage (#10%) or
almost complete leakage ($85%), as illustrated in Figure 1E–H for
POPC/POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine/
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol). A clear length
dependent effect is thus observed, indicating that leakage can only occur
when the peptides are long enough to span the hydrophobic part of the
lipid bilayer. The results for all lipid systems under investigation are
summarized for P/L 5 1512.5 in Table 3.
In the typical membrane lipids POPC/POPG (with C16:0/C18:1
chains) no leakage was observed for KIA14 and KIA15, but KIA17
and longer peptides induced almost complete leakage. In thick
Table 2 | MIC values (mg/mL) for KIA peptides in four different bacterial strains. Inactive peptides are marked in bold for each strain
Peptide
Gram-negative Gram-positive
E. coli P. aeruginosa S. aureus E. faecalis
KIA14 .256 .256 .256 .1024
KIA15 .256 .256 .256 .1024
KIA17 32 256 256 .1024
KIA19 32 256 .256 .1024
KIA21 4 64 8 1024
KIA22 4 32 16 1024
KIA24 4 16 4 64
KIA26 4 16 8 64
KIA28 8 16 8 16
PGLa (control) 32 256 64 .1024
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Figure 1 | (A–D) Hemolysis of KIA peptides, measured at four different peptide concentrations. (E–H) Leakage induced by KIA peptides in POPC/
POPG (151) vesicles, measured at four different peptide-to-lipid ratios (P/L). At high peptide concentration the short peptides give no leakage, but KIA17
and longer peptides give 100% leakage.
www.nature.com/scientificreports
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bilayers composed of DErPC/DErPG (1,2-dierucoyl-sn-glycero-
3-phosphatidylcholine/1,2-dierucoyl-sn-glycero-3-phosphatidylgly-
cerol) (with di-C22:1 chains) there was also a threshold, but now only
KIA24 and longer peptides gave rise to leakage. We also examined a
set of lipidmixtures with zwitterionic PC and anionic PG, whose acyl
chain lengths were significantly mismatched to one another. Since
lateral phase segregation is expected to occur in these cases, we
intended to find out whether either the anionic or the uncharged
lipid domains would be targeted by the peptide. The data in Table 3
show that the threshold length of the peptides is dominated by the
charged PG component. The pattern in the well-matched POPC/
POPG mixture is identical to that in the length-unbalanced
DMoPC/DOPG (1,2-dimyristoleoyl-sn-glycero-3-phosphatidylcho-
line, di-C14:1-PC/1,2-dioleoyl-sn-glycero-3-phosphatidylglycerol,
di-18:1-PG) and DErPC/POPG systems: KIA17 or longer peptides
gave total leakage, even if the PC lipids were significantly shorter or
longer than the anionic component. Less extreme is the case for
POPC/DErPG, where 21 residues are required to induce leakage,
hence this threshold is in between that of POPC/POPG and
DErPC/DErPG.
An interesting fluctuating pattern emerges not only in Table 3, but
also in the leakage and hemolysis panels of Figure 1, where it had
been left uncommented so far. Certain peptides are obviously less
active than their next shorter neighbor (for example, KIA19 is less
active than KIA17 in DErPC/POPG, and KIA26 is less active than
KIA24 inDErPC/DErPG). In all these cases, membrane perturbation
is seen to occur also for the longer peptide, but to a lower extent or
with a lower rate (see kinetic data in Supplementary Figure S2). The
common denominator of the more active peptides is the fact that
they all carry a hydrophobic unit Ile-Ala at the C-terminus, while the
longer, less active peptides all end with a charged Lys.
Solid-state NMR. Pore formation induced by an amphipathic
peptide must be accompanied by its insertion into a transmem-
brane state. The actual orientation of an a-helical peptide in a
bilayer can be determined from a solid-state NMR analysis in
oriented membrane samples, by observing the chemical shift of a
15N-label in the peptide backbone52. All KIA peptides were
synthesized with a 15N-amide at Ala-10 to perform such 15N-NMR
experiments in a well-defined lipid bilayer system. DMPC is the
most convenient lipid that aligns well in oriented NMR samples
and does not suffer from oxidation13,14,20,53–55. 15N-NMR spectra of
the different KIA peptides reconstituted in DMPC at a P/L ratio of
1520 are given in Figure 2B, and Figure 2A/2C shows the
corresponding 31P-NMR line shapes of the phospholipid matrix.
The 31P-NMR spectra were collected before and after the 15N-
experiments, in order to check for any perturbations in the lipid
bilayer that may be induced by the peptide, or that could occur as
a result of sample dehydration during the long 15N-measurements.
A striking length-dependent re-alignment behavior of the KIA
peptides is observed by solid-state NMR. The 15N-NMR signals of
KIA14 and KIA15 at 90 ppm are indicative of a surface-bound ori-
entation, while KIA17 and KIA19 give a chemical shift around
150 ppm representing a highly tilted state, in which the peptides
reach deeply into the membrane. This fits with the leakage results
in POPC/POPG where KIA14 and KIA15 were not active, while
KIA17 and longer peptides induced leakage (see Figure 1). KIA21
shows a broader line shape with 15N-signals between 150 ppm and
90 ppm, suggesting that this peptide is no longer oriented in a uni-
form way but instead assumes a range of different tilt angles. The
longest peptides from KIA22, KIA24, KIA26 to KIA28 then become
Table 3 | Leakage induced by KIA peptides in vesicles with different acyl chain composition. The percentage of leakage is taken after 10
minutes at P/L51512.5, relative to the level upon the addition of Triton X-100 (defined as 100% leakage). The length of the peptides and the
hydrophobic thickness of the bilayers (corresponding to the pure lipids) are also given. Inactive peptides are marked in bold for the different
lipid systems
Lipid DMoPC/DOPG POPC/POPG DErPC/POPG POPC/DErPG DErPC/DErPG
Peptide Length (A˚) 19.2a/27.5b 27.1c/27.8b 34.4c/27.8b 27.1c/34.4c 34.4c/34.4c
KIA14 21 8 3 5 2 1
KIA15 22.5 3 2 3 2 0
KIA17 25.5 100 100 84 17 1
KIA19 28.5 100 100 30 4 2
KIA21 31.5 100 100 98 82 4
KIA22 33 100 100 85 26 6
KIA24 36 100 100 100 100 89
KIA26 39 100 100 100 97 10
KIA28 42 100 100 100 100 84
aValue from Ref. 62.
bValue from Ref. 64.
cValue from Ref. 63.
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A B C
Figure 2 | Solid-state NMR spectra of KIA peptides in DMPC at P/L 5
1520. (A) 31P-NMR spectra before 15N-NMR. (B) 15N-NMR spectra. (C)
31P-NMR spectra after 15N-NMR. The 15N-NMR signal of KIA14 and
KIA15 at 90 ppm (blue dotted line) is typical of the surface-bound state. It
shifts to 150 ppm (red line), indicating an inserted state for KIA17 and
some longer peptides. For KIA22 and the even longer peptides, broad
powder line shapes are seen in 15N-NMR (with a peak also at 90 ppm), and
the 31P-NMR spectra show a perturbed lipid bilayer.
www.nature.com/scientificreports
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completely disordered, as their spectra turn into broad powder
patterns (giving signals between 220 and 60 ppm, with a maximum
around 90 ppm). Interestingly, these long peptides are also found to
induce considerable perturbation in the membrane, as seen in the
31P-NMR spectra (broad upfield powder component with a max-
imum around 0 ppm in panels 2A/2C). These 31P and 15N powder
line shapes indicate that the longest peptides no longer have a pre-
ferred alignment and strongly disturb the lipid bilayer (at least for the
high P/L ratio used here to obtain sufficient sensitivity for the 15N-
NMR measurements). The NMR data in DMPC can thus be inter-
preted in terms of a length-dependent insertion of the KIA peptides;
the shortest ones are surface-bound and remain inactive, but when
the peptide length matches that of the lipid bilayer the helices can
insert deeply into the membrane and become active. If the peptides
are too long to span the hydrophobic bilayer core, they will no longer
take on a well-defined alignment but lead to considerable disorder in
the lipidmatrix, which is also a sign ofmembrane damage, which can
occur in several ways.
Discussion
In this study, we have systematically explored how the length of
amphipathic a-helical peptides affects their membranolytic activ-
ity. Nine model peptides with lengths from 14 to 28 amino acids
were constructed from simple repeats of the sequence KIAGKIA.
CD showed that all peptides are mostly a-helical in DMPC/
DMPG vesicles (Figure S1, Table 1). We have previously per-
formed solid-state 19F-NMR experiments in both DMPC/DMPG
and in bacterial and erythrocyte membranes of several AMPs, and
found the same structure and orientation of peptides in both
DMPC/DMPG and in biological membranes56,57, supporting the
conclusion that the KIA peptides are a-helical also in biological
membranes.
We found that (i) their antimicrobial activities exhibit a distinct
length-dependent threshold, which interestingly differs for different
bacterial strains. Similarly, (ii) the hemolytic effect increases abruptly
with peptide length, and (iii) a fluorescence leakage assay with syn-
thetic lipid vesicles also showed that a minimum peptide length is
required that matches the bilayer thickness.
All these results are consistent with the classical - but recently
questioned41–45 - hypothesis of peptide pore formation. The intuitive
idea is that amphipathic peptides form transmembrane pores in the
lipid bilayer with essentially upright helices, according to the Shai-
Matsuzaki-Huang model of a ‘‘toroidal wormhole’’58,59 or a ‘‘barrel-
stave’’ pore60. The measured leakage can be explained by assuming
that only aminor part of themembrane-bound peptides are involved
in forming the pores61. Figure 3 illustrates that such pores should
only be feasible if the peptide is long enough to span the membrane,
while shorter peptides should stay on the membrane surface and
remain inactive. Our results do not only provide new and unambigu-
ous evidence to support this concept, which had so far been based
merely on indirect observations. Furthermore, the systematic leakage
data now allow us to perform a quantitative analysis of the length-
dependent effects, as the lipid acyl chains are well defined and the
membrane thickness of the vesicles is known.
The length of an ideal a-helical peptide is 1.5. A˚ per residue. The
residues close to the termini might not be in an ideal a-helical con-
figuration, which could make the peptide longer or shorter depend-
ing on the exact local structure, whichmight also fluctuate over time.
We will estimate the length of the KIA peptides to be as a first
approximation 1.5 A˚ per residue, but this might be a few A˚ away
from the real value. The hydrophobic thickness has been determined
experimentally for many synthetic lipid bilayers. For lipids where no
data is available, the thickness can be approximated using formulae
according to Marsh62. Table 3 thus gives the peptide lengths and
hydrophobic thickness of the lipid bilayers used, indicating at the
same time whether or not a certain peptide/lipid combination leads
to vesicle leakage. ForDErPC/DErPG there is a very clear correlation,
as only those peptides longer than the hydrophobic thickness of
34.4 A˚63 can induce leakage. In POPC/POPG, the KIA17 peptide
with an approximate length of 25.5 A˚ already induces leakage, being
only marginally shorter than the bilayer thickness of about
27.1 A˚63,64. It should be noted that the hydrophobic thickness is
not the full membrane thickness, but only the thickness of the hydro-
phobic core. For example, in POPC, the hydrophobic thickness is
27.1 A˚, while the distance between the average planes of the phos-
phate groups on each side of the bilayer is 37.6 A˚, and the ‘‘steric
thickness’’ between the outer surfaces of the lipid head groups is
45.1 A˚63. In other words, the amphipathic helices only need to be
long enough to span the hydrophobic part of the membrane to be
active, not the entire membrane. If the peptides are longer, they can
also easily span part of themore polar head group region and become
more tilted.
This structural behavior is nicely seen in the solid-state 15N- and
31P-NMR analyses of the different KIA peptides, carried out in a well-
defined model membrane system, as previously explained in more
detail21,24. A distinct length-dependent re-alignment is observed here
in DMPC, as illustrated in Figure 3. When the helices are too short
they remain surface-bound and inactive (i.e. KIA14 and KIA15).
Only KIA17 with a threshold length of 25.5 A˚ is found to insert in
a well-defined manner, being perfectly matched to the hydrophobic
thickness of 25.4 A˚65 and obviously able to form a stable membrane-
spanning pore. When the peptides are too long (i.e. 31.5 A˚ for
KIA21) they become disordered and lead to considerable membrane
perturbation, which still accounts for their high membranolytic
activity.
foldingbinding
No pores formed Pores are formed
Peptide too short
to span the membrane
Peptide matching
membrane thickness
Peptide longer than
membrane thickness
No vesicle leakage
No bacterial killing
No hemolysis
Vesicle leakage
Bacterial killing
Hemolysis
Figure 3 | Schematic illustration of the pore formation mechanism
proposed to occur for KIA peptides. The peptides are unstructured in
solution but form amphipathic a-helices when bound to the membrane,
according to CD spectroscopy. If the peptide is too short to span the
hydrophobic lipid bilayer core, no pores are formed and the helix remains
flat on the membrane surface. If the peptide length matches the bilayer
thickness, a transmembrane pore can form with peptides in an inserted,
upright orientation. (Pores are depicted as barrel-staves for simplicity of
drawing, though they may well be of the toroidal wormhole type with lipid
head groups lining the pore).
www.nature.com/scientificreports
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From these findings we conclude that only peptides long enough
to span the hydrophobic membrane core can form pores that are
responsible for leakage. Of course, there are still numerous situations
in which leakage is weak or does not occur at all, even though the
peptide is in principle long enough. Many reasons can be named for
such lack in activity. A straightforward explanation holds in those
cases where the total peptide concentration is simply too low, as seen
for example in the hemolysis and leakage panels of Figure 1A/B/E.
The total weight of peptide in these assays always makes an under-
lying contribution to the observed activity, but cannot account for
the abrupt length-dependent jumps discussed here. Another scen-
ario with unexpectedly low activity has been noted for the KIA pep-
tides terminating with a charged residue. In all assays (MIC,
hemolysis, leakage) those peptides with a hydrophobic Ile-Ala at
the C-terminus tend to be more active than their next longer neigh-
bor with Lys. These subtle effects seem to be due to the actual residues
at the end of the helix, as Lys renders the C-terminus more polar and
seems to make its insertion into the bilayer core less favorable.
We have indeed shown in a recent comprehensive solid-state
NMR structure analysis of KIA21 (formerly called MSI-103,
[KIAGKIA]3-NH2) that it is the hydrophobic C-terminus that starts
to tilt into the membrane, in line with the fact that the sequence
carries a charged Lys at the N-terminus like all KIA peptides20,24.
This kinetic effect is supported by the slower rates of leakage
observed for those peptides with a C-terminal Lys (see Supple-
mentary Figure S2).
Another reason for a low membranolytic activity of AMPs can
often be attributed to a lack of initial membrane binding due to
electrostatic attraction. The bacterial membranes employed above
in the MIC tests are rich in anionic lipids anyway, and also in the
hemolysis assays the KIA peptides showed a sufficient membrane
binding affinity. To encourage membrane binding, we included
anionic lipids in the fluorescence vesicle leakage assays (though this
was not necessary in the solid-state NMR samples as they contain no
excess water into which the peptide could escape from the oriented
multibilayers). In themixed vesicle preparations where the acyl chain
lengths of the PC and PG lipids were not the same, we found that the
threshold length for the peptides is determined largely by the anionic
lipid component. DMoPC/DOPG andDErPC/POPG show the same
threshold as POPC/POPG, even though the PC lipids have very
different acyl chain lengths [19.2 A˚ for DMoPC with di-14:1
chains62; 34.4 A˚ for DErPC with di-22:1 chains63], while DOPG
has a length (27.5 A˚)64 comparable to that of POPG (27.8 A˚)64. For
the case of POPC/DErPG, the threshold lies in between that of
POPC/POPG and DErPC/DErPG. These observations lead to the
conclusion that the cationic KIA peptides are attracted to the mem-
brane surface by the negatively charged PG lipids, with which they
will most likely form PG-rich domains, as previously shown for
KIA21 (MSI-103)66. Even if all these conditions are fulfilled (electro-
static attraction, sufficiently high peptide concentration, suitable ter-
mini), the peptidemust nevertheless be long enough to span this lipid
domain in order to form pores.
Synthetic lipids with known acyl chain lengths were employed in
the leakage experiments, but natural biomembranes contain a variety
of lipids with different chains and head groups, plus other compo-
nents like membrane proteins and cholesterol. Therefore, the actual
membrane hydrophobic thickness is unknown in our biological
assays on bacteria and erythrocytes. Assuming that the cells are killed
by pores, formed the same way as in the vesicle leakage experiments,
we can now use the KIA peptides as molecular rulers to obtain
information about their effective membrane thickness. Both in
Gram-positive and Gram-negative bacteria, the relevant membrane
is the (inner) cytoplasmic membrane.
In E. coli, we found that the shortest peptide able to kill the bacteria
is KIA17, which is at the same time the shortest peptide able to induce
leakage in POPC/POPG membranes. Thus, the hydrophobic mem-
brane thickness of E. coli should be similar to POPC/POPG, i.e.
around 27 A˚, at least for the anionic lipid components or domains
thereof. According to an X-ray scattering analysis, the observed
thickness of the E. coli inner membrane, measured as the average
distance between phosphate groups on opposite sides of the bilayer,
is 37.5 A˚67. This value fits very well with the corresponding distance
measured in POPC bilayer, which was found to be 37.6 A˚, and
translates into a hydrophobic thickness of 27.1 A˚63.
For other bacteria we have not found any data on membrane
thickness in the literature, but we can now use our results on KIA
peptides to estimate them. E. faecalis was killed only by KIA24 and
longer peptides, which were also needed to induce leakage inDErPC/
DErPG. Therefore, the hydrophobic thickness of theE. faecalismem-
brane should be similar to DErPC/DErPG, namely around 34 A˚. In
P. aeruginosa and S. aureus the membranes should be around 31 A˚
thick, as these bacteria are killed by KIA21, but not by any of the
shorter peptides. For hemolysis of erythrocytes, the threshold was
not so clear-cut, but only KIA21 and longer peptides showed a pro-
nounced effect at high concentration, so these eukaryotic mem-
branes seem to have a similar hydrophobic thickness as those of S.
aureus and P. aeruginosa, namely around 31 A˚. In one study, from
electronmicroscopy the hydrophobic thickness of erythrocyte mem-
branes was estimated to be,25 A˚, and fromX-ray diffraction a head
group separation of ,48 A˚ was found68, which considering experi-
mental uncertainties is compatible with our results here.
In the literature, many groups have studied the effect of peptide
length on the activity of AMPs33–40, but to the best of our knowledge
no quantitative studies on the matching of peptide length withmem-
brane thickness have been reported. For magainin 2 with 23 amino
acids, it was found that the full activity against E. coli was retained
when 3 N-terminal residues were removed; with 4 residues removed
the activity was reduced, and when 5 or 6 amino acids were removed
the activity was completely lost33. These results imply that 19 amino
acids are needed for proper activity against E. coli, similar to what we
find here for the KIA peptides. Since magainin 2 is believed to form
pores in a similar way to PGLa8–10, the parent peptide in the design of
the KIA peptides, this similar threshold length further supports the
pore-forming hypothesis.
In several previous reports, amphipathic a-helical model peptides
had been designed and their antimicrobial activities were tested as a
function of length. In some cases, like in the present study, a min-
imum length was found to be necessary for activity, and all longer
analogs were also active34–36. We can thus assume that these kinds of
peptides kill bacteria in the same manner as the KIA peptides, by
forming pores across the membrane with peptides in a transmem-
brane orientation. However, in some other studies a different beha-
vior was found, with amaximum activity for a certain peptide length,
and less activity for both longer and shorter sequences37–40. Often, the
highest activity was found for peptides too short to be expected to
form pores, namely for around 1537,38 or even 12 amino acids39,40.
Also some other short amphipathic a-helical peptides, like BP100
with 11 amino acids48,49, have a high antimicrobial activity, but seem
much too short to form transmembrane pores. For those peptides, a
different mechanism must be responsible for their membranolytic
activity, for example the ‘‘carpet’’ model46.
Conclusions
Using a series of model amphipathic a-helical peptides of different
length from 14 to 28 amino acids, we have been able to demonstrate
that (i) antimicrobial peptides can align in the membrane to form
transmembrane pores, (ii) they require a distinct bilayer length
dependent threshold to be active, (iii) this length dependence can
be explained by hydrophobic (mis)matching (a well-known fun-
damental concept that had so far only been developed for and applied
to hydrophobic peptides or protein segments25,30–32 and now is
extended also to amphipathic helices, and (iv) our biological results
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show that the length-dependent activity can be used to estimate the
thickness of different bacterial (or eukaryotic) cellular membranes in
vivo. We also expect this study to be of help for the design of new
AMPs that could be useful as future antibiotic drugs.
Methods
Materials. Peptide synthesis reagents and Fmoc-protected amino acids were
purchased from Merck Biosciences (Darmstadt, Germany) and/or Iris Biotech
(Marktretwitz, Germany). 15N-labelled amino acids were purchased from Cambridge
Isotope Laboratories (Andover, MA, USA) and were Fmoc-protected using Fmoc-Cl
as described previously69. Solvents for peptide synthesis were purchased fromMerck
(Darmstadt, Germany) or from Biosolve (Valkenswaard, Netherlands) and solvents
for HPLC purification were obtained from Fischer Scientific (Geel, Belgium). The
lipids 1,2-dierucoyl-sn-glycero-3-phosphatidylcholine (DErPC), 1,2-dierucoyl-sn-
glycero-3-phosphatidylglycerol (DErPG), 1,2-dimyristoyl-sn-glycero-3-
phosphatidylcholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-phosphatidylglycerol
(DMPC), 1,2-dimyristoleoyl-sn-glycero-3-phosphatidylcholine (DMoPC), 1,2-
dioleoyl-sn-glycero-3-phosphatidylglycerol (DOPG), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphatidylcholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphatidylglycerol (POPG), and 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Rhod-PE) were
obtained from Avanti Polar Lipids (Alabaster, USA). The fluorescent probes 8-
amino-naphtalene-1,3,6-trisulfonic acid sodium salt (ANTS) and
pxylenebis(pyridinium)bromide (DPX) were obtained from Invitrogen - Molecular
Probes (Karlsruhe, Germany).
Peptide synthesis. KIA peptides were synthesized on an automated Syro II multiple
peptide synthesizer (MultiSynTech, Witten, Germany), using standard Fmoc solid
phase peptide synthesis protocols20,70. The crude peptides were purified using a high-
pressure liquid chromatography (HPLC) device from JASCO (Groß-Umstadt,
Germany) on a preparative Vydac C18 column using a water/acetonitrile gradient
supplemented with 5 mM HCl. The purified peptides were characterized by using
analytical LC (Agilent; Waldbron, Germany) coupled to an ESI mass spectrometer
(mTOF Bruker, Bremen, Germany) and were found to be over 95% pure.
Circular dichroism spectroscopy (CD). CD samples were prepared by co-
solubilizing DMPC and DMPG (351 mol/mol) in chloroform/methanol 351 (v/v).
After drying, the lipid film was dispersed in phosphate buffer (10 mM, pH 7) and
homogenized by vortexing. Small unilamellar vesicles (SUVs) for CD samples were
generated by sonication in a high-power ultrasonic bath with a beaker-shaped
sonotrode (UTR 200, Hielscher, Germany). CD spectra were recorded on a J-815
spectropolarimeter (JASCO, Groß-Umstadt, Germany) between 260 and 185 nm at
0.1-nm intervals, using 1-mm quartz glass cells (Suprasil; Hellma, Mu¨llheim,
Germany) at 20uC, as reported previously51. The peptides were measured at 20uC in
10 mM sodium phosphate buffer (pH 7.0) and at 30uC in lipid vesicles composed of
DMPC/DMPG (351). Typical peptide concentrations of the final samples in
phosphate buffer was 36–72 mM, and for the vesicle samples 30 mM with a peptide-
to-lipid molar ratio (P/L) of 1550. An averaged baseline of the pure solvent or lipid
matrix, respectively, was subtracted. Finally, the spectra were converted to mean
residue ellipticities (MRE) by using the weighed-in peptide amount and the volume of
the sample for concentration determination. The peptide stocks contain some salt
after HPLC, and some water might be present, but the material had to be weighed in,
as the KIA peptides do not contain any aromatic amino acids for calibration by UV/
VIS absorption. Although this ambiguity in peptide concentration leads most
probably to an underestimation of the magnitude of the MRE values we attempted a
quantitative deconvolution of CD data to estimate the relative contents of different
secondary structure elements. If part of the weighted material was not peptide, this
leads to an underestimating of theMRE, which also leads to an underestimation of the
helical content71. The values obtained are thus the minimum helical content of each
peptide.
Secondary structure estimation from CD spectra was performed using the
CONTIN-LL program, which is based on the ridge regression algorithm72,73. The
algorithm is provided by the DICHROWEB on-line server74. The quality of the fit
between experimental and back-calculated spectrum corresponding to the estimated
secondary structure fractions was assessed from the normalized root mean square
deviation (NRMSD), with a value ,0.1 considered as a good fit74.
MIC (minimum inhibitory concentration) assay. Antimicrobial activity was
measured by a standard MIC assay, carried out with Gram-positive Staphylococcus
aureus (DSM 1104) and Enterococcus faecalis (DSM 2570) and with Gram-negative
Escherichia coli (DSM 1103) and Pseudomonas aeruginosa (DSM 1117), as previously
reported53. Briefly, bacteria were grown inMu¨ller-Hintonmedium at 37uC overnight.
Microtiter plates (96 wells of 100 mL) were filled with 50 mL of Mu¨ller-Hinton
medium, and serial 2-fold dilutions of peptides were arranged in quadruple. The two
final rows of each plate remained without peptide, so that the penultimate data point
served as the positive control (no peptide), and the final one as the negative control
(not inoculated). 50 mL of bacterial suspension (OD 5 0.2) was added to the wells
(except for the final row of each plate) to give a final concentration of 106 colony-
forming units (CFU)/mL. The plates were incubated at 37uC for 20 h, and the MIC
value was determined visually on the basis of turbidity as the lowest peptide
concentration inhibiting bacterial growth.
Hemolysis assay.Hemolytic activity was examined with a serial 2-fold dilution assay
as previously described7. Citrate phosphate dextrose-stabilized blood bags with
erythrocyte suspensions of healthy donors were obtained from the blood bank of the
local municipal hospital (Sta¨dtisches Klinikum, Karlsruhe, Germany). The
erythrocytes, previously washed, were incubated with peptide solutions at 37uC for
30 min with gentle shacking. The tubes were centrifuged at 13000 rpm for 10 min to
pellet the cells, and the absorbance at 540 nmwas recorded against a negative control
(cells without peptide, accounting for autohemolysis). The percentage of lysis was
then calculated relative to 100% lysis induced by 1% Triton X-100. The absorbance
measurements were repeated three times, and the averaged values were used.
Vesicle leakage assay. For the leakage experiments75, the buffer in which the vesicles
were prepared contained the fluorophor ANTS (12.5 mM), the quencher DPX
(45 mM), 50 mM NaCl, and 10 mM HEPES (pH 7.5). Liposomes were prepared by
co-dissolving PC/PG 151 (mol/mol) mixtures of the lipids with different chain length
in CHCl3/MeOH (351 v/v), together with 1022 mol% Rhod-PE by which the lipid
loss during vesicle preparation (extrusion and gel filtration, see below) could be
quantified. The peptide-to-lipid ratio (P/L) is given inmol/mol. The lipidmixture was
dried underN2(g) and left to dry under vacuum overnight. The obtained thin filmwas
then re-suspended in the buffer which contained the fluorophor and the quencher by
vigorous vortexing, followed by 10 freeze-thaw cycles. Large unilamellar vesicles
(LUV) were obtained by 21-fold extrusion (Avanti Mini Extruder; Avanti Polar
Lipids, Alabaster, AL) of the liposomes through a Nuclepore polycarbonate
membrane (pore size 100 nm, Whatman - GE Healthcare Europe, Freiburg,
Germany) at a temperature 20uC above the lipid phase transition. Unencapsulated
dye was removed by gel filtration using spin columns filled with Sephacryl 100-HR
(Sigma-Aldrich, Taufkirchen, Germany), and equilibrated with an elution buffer
(150 mM NaCl, 10 mM HEPES, pH 7.5) which balances the internal vesicle
osmolarity.
Leakage of entrapped ANTS was monitored by fluorescence dequenching of
ANTS76. Fluorescencemeasurements were performed in a thermostatted cuvette with
constant stirring at 30uC in the same buffer as used for gel filtration on a FluoroMax2
spectrofluorimeter (HORIBA Jobin Yvon, Unterhaching, Germany) by setting the
ANTS emission to 510 nm (5 nm slit) and its excitation to 355 nm (5 nm slit). The
vesicles (100 mM lipid final concentration) of the desired composition were added to
the cuvette containing the peptide at the P/L ratio to be tested (from 1 mM stock
solutions in water). The level of 0% leakage corresponded to the fluorescence of the
vesicles immediately after their addition, while 100% leakage was the fluorescence
value obtained after addition of a 0.25 vol-% Triton X-100 after 10 min.
Solid-state NMR. Macroscopically oriented NMR samples were prepared by co-
dissolving appropriate amounts of peptides and lipids (in 300 ml methanol, 100 ml
CHCl3, and 10–20 ml milliQ-water), and spreading onto 23 thin glass plates of
dimensions 9 mm3 7.5 mm3 0.08 mm (Marienfeld Laboratory Glassware, Lauda-
Ko¨nigshofen, Germany). The peptide-to-lipid ratio (P/L) is given in mol/mol. The
plates were dried in air for 1 h, followed by drying under vacuum overnight. They
were stacked and placed into a hydration chamber with 96% relative humidity at 48uC
for 18–24 h, before wrapping the stack in parafilm and plastic foil for the NMR
measurements.
All solid-state NMR measurements were carried out on a Bruker Avance 500 or
600 MHz spectrometer (Bruker Biospin, Karlsruhe, Germany) at 308 K. 31P-NMR
was used to check the quality of the lipid orientation in the samples, using a Hahn
echo sequence with 1H decoupling and phase cycling. 1H-15N cross polarization
experiments using a CP-MOIST pulse sequence77 were performed using a double-
tuned probe with a low-E flat-coil resonator (3 mm 3 9 mm cross section),
employing a 1H and 15N radiofrequency field strength of 65 kHz during the cross
polarization, and 36 kHz 1H SPINAL16 decoupling during acquisition. A mixing
time of 500 ms was used, and 10000 to 30000 scans were accumulated. The acquisition
time was 10 ms and the recycle time 4 s. The 15N chemical shift was referenced using
the signal of an ammonium sulfate sample set to 26.8 ppm. The oriented membrane
samples were placed in the flat-coil probe such that the lipid bilayer normal was
aligned parallel to the magnetic field.
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